Sheel Biotech Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 4.14 Cr
as on 18-07-2024
- Company Age 33 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.23 Cr
as on 18-07-2024
- Satisfied Charges ₹ 1.68 Cr
as on 18-07-2024
- Revenue 12.84%
(FY 2023)
- Profit 7.63%
(FY 2023)
- Ebitda 38.65%
(FY 2023)
- Net Worth 6.02%
(FY 2023)
- Total Assets 0.68%
(FY 2023)
About Sheel Biotech
The Corporate was formerly known as Sheel Biotech Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 4.14 Cr.
The company currently has active open charges totaling ₹21.23 Cr. The company has closed loans amounting to ₹1.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sumeet Chandak, Sanjay Chandak, and Ramesh Srivastava serve as directors at the Company.
- CIN/LLPIN
U24239DL1991PLC046531
- Company No.
046531
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Nov 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sheel Biotech Limited offer?
Sheel Biotech Limited offers a wide range of products and services, including Landscape Structure and Designing, Gardening Service, Organic Food Grains & Vegetables, Organic Oils, Cooking Spices and Masala, Masala Powder, Landscaping Services, Fresh Flowers, Plants & Trees, Fruit Plants, Organic Sugar.
Who are the key members and board of directors at Sheel Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Chandak  | Director | 12-Oct-2011 | Current |
| Sumeet Chandak | Director | 21-Nov-1996 | Current |
| Ramesh Srivastava | Director | 31-Mar-2023 | Current |
Financial Performance of Sheel Biotech.
Sheel Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.84% increase. The company also saw a slight improvement in profitability, with a 7.63% increase in profit. The company's net worth moved up by a moderate rise of 6.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sheel Biotech?
In 2023, Sheel Biotech had a promoter holding of 96.36% and a public holding of 3.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rajendra Pusa Agritech And Services Private LimitedActive 2 years 10 months
Ramesh Srivastava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 29 Jul 2022 | ₹1.60 M | Open |
Indian Overseas Bank Creation Date: 16 Sep 2021 | ₹5.12 M | Open |
Indian Overseas Bank Creation Date: 20 May 2021 | ₹1.56 M | Open |
How Many Employees Work at Sheel Biotech?
Sheel Biotech has a workforce of 53 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sheel Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sheel Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
